Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter,...

Area of Science:

• Neurology
• Medical Technology
• Clinical Trials

Background:

• Deep brain stimulation (DBS) is a key treatment for Parkinson's disease (PD).
• DBS programming is time-consuming and burdensome for patients, caregivers, and clinicians.
• Optimizing DBS programming is crucial for treatment efficacy.

Purpose of the Study:

• To evaluate the efficacy of the Mobile Application for PD DBS (MAP DBS) system.
• To determine if MAP DBS improves DBS programming efficiency and clinical outcomes in PD patients.
• To assess the impact of MAP DBS on programming time, motor symptoms, and caregiver strain.

Main Methods:

• An open-label, randomized controlled trial comparing standard of care (SOC) with MAP DBS-aided programming.
• Six months of follow-up in patients aged 30-80 with idiopathic PD undergoing DBS.
• Primary outcome: time spent on DBS programming. Secondary outcomes: UPDRS motor scores, caregiver strain, medication needs.

Main Results:

• MAP DBS significantly reduced initial programming visit time (27.4 min vs. 43.8 min, p=0.001).
• No significant difference in total programming time over six months.
• MAP DBS group showed greater improvement in UPDRS III motor scores (-7.0 vs. -2.7, p=0.01).

Conclusions:

• MAP DBS is well-tolerated and improves initial DBS programming efficiency.
• MAP DBS enhances clinical efficacy by improving motor symptoms in Parkinson's disease patients.
• This clinical decision support system shows promise for optimizing DBS therapy.